- Benzinga•6 days ago
Reviewing the data from the second arm of DexCom, Inc.'s (NASDAQ: DXCM ) Diamond study, Baird said the results are positive for Continuous Glucose Monitoring , or CGM, and modestly positive, or at least ...
- TheStreet.com•6 days ago
The continuous glucose monitor maker is an excellent growth opportunity.
- Motley Fool•16 days ago
These three stocks promise fast growth for those daring enough to invest.
DXCM : Summary for DexCom, Inc. - Yahoo Finance
DexCom, Inc. (DXCM)
NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
|Bid||71.10 x 100|
|Day's Range||79.68 - 82.23|
|52 Week Range||56.52 - 96.38|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-116.81|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|